Literature DB >> 19892940

Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation.

Senthil K Venugopal1, Joy Jiang, Tae-Hun Kim, Yong Li, Si-Si Wang, Natalie J Torok, Jian Wu, Mark A Zern.   

Abstract

Activation of hepatic stellate cells (HSC) results in their proliferation and in the secretion of extracellular matrix (ECM) proteins, which leads to hepatic fibrosis. microRNAs (miRNAs) have been shown to regulate various cell functions, such as proliferation, differentiation, and apoptosis. Hence, we have analyzed the miRNAs that were differentially expressed in HSC isolated from sham-operated and bile duct-ligated rats. Expression of two miRNAs, miRNA-150 and miRNA-194, was reduced in HSC isolated from fibrotic rats compared with sham-operated animals. These two miRNAs were overexpressed in LX-2 cells, and their ability to inhibit cell proliferation, the expression of smooth muscle alpha-actin (SMA), a marker for activation, and collagen type I, a marker for ECM secretion, was determined. Overexpression of these two miRNAs resulted in a significant inhibition of proliferation (P < 0.05) and reduced SMA and collagen I levels compared with either untreated cells or nonspecific miRNA-expressing cells. Next, the protein targets of these two miRNAs were found using bioinformatics approaches. C-myb was found to be a target for miRNA-150, and rac 1 was found to be one of the targets for miRNA-194. Therefore, we studied the expression of these two proteins by overexpressing these two miRNAs in LX-2 cells and found that overexpression of miRNA-150 and miRNA-194 resulted in a significant inhibition of c-myb and rac 1 expression, respectively. We conclude that both miRNA-150 and miRNA-194 inhibit HSC activation and ECM production, at least in part, via inhibition of c-myb and rac 1 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892940      PMCID: PMC2806096          DOI: 10.1152/ajpgi.00220.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  25 in total

Review 1.  Transcriptional regulation in hepatic stellate cells.

Authors:  F J Eng; S L Friedman
Journal:  Semin Liver Dis       Date:  2001-08       Impact factor: 6.115

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

3.  Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation.

Authors:  Juling Ji; Jinsheng Zhang; Guangcun Huang; Jin Qian; Xueqing Wang; Shuang Mei
Journal:  FEBS Lett       Date:  2009-01-29       Impact factor: 4.124

4.  MicroRNAs make inroads into liver development.

Authors:  Charles E Rogler
Journal:  Gastroenterology       Date:  2009-01-23       Impact factor: 22.682

Review 5.  The myb oncogene.

Authors:  G L Shen-Ong
Journal:  Biochim Biophys Acta       Date:  1990-06-01

6.  Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis.

Authors:  J Zhu; J Wu; E Frizell; S L Liu; R Bashey; R Rubin; P Norton; M A Zern
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

7.  The microRNA-30 family is required for vertebrate hepatobiliary development.

Authors:  Nicholas J Hand; Zankhana R Master; Steven F Eauclaire; Daniel E Weinblatt; Randolph P Matthews; Joshua R Friedman
Journal:  Gastroenterology       Date:  2008-12-09       Impact factor: 22.682

8.  Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage.

Authors:  Hitoshi Shirahashi; Jian Wu; Naoki Yamamoto; Andreea Catana; Henning Wege; Brook Wager; Kiwamu Okita; Mark A Zern
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

9.  Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential.

Authors:  Henning Wege; Hai T Le; Michael S Chui; Li Liu; Jian Wu; Ranjit Giri; Harmeet Malhi; Baljit S Sappal; Vinay Kumaran; Sanjeev Gupta; Mark A Zern
Journal:  Gastroenterology       Date:  2003-02       Impact factor: 22.682

10.  Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.

Authors:  S Milani; H Herbst; D Schuppan; C Grappone; G Pellegrini; M Pinzani; A Casini; A Calabró; G Ciancio; F Stefanini
Journal:  Am J Pathol       Date:  1994-03       Impact factor: 4.307

View more
  89 in total

Review 1.  Targeting collagen expression in alcoholic liver disease.

Authors:  Kyle J Thompson; Iain H McKillop; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

2.  Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells.

Authors:  Jiang Li; Yifei Zhang; Ramalinga Kuruba; Xiang Gao; Chandrashekhar R Gandhi; Wen Xie; Song Li
Journal:  Mol Pharmacol       Date:  2011-04-21       Impact factor: 4.436

Review 3.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease.

Authors:  Thomas A Wynn; Thirumalai R Ramalingam
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 4.  New tricks from an old oncogene: gene fusion and copy number alterations of MYB in human cancer.

Authors:  Göran Stenman; Mattias K Andersson; Ywonne Andrén
Journal:  Cell Cycle       Date:  2010-08-28       Impact factor: 4.534

5.  Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.

Authors:  Ashley M Lakner; Nury M Steuerwald; Tracy L Walling; Sriparna Ghosh; Ting Li; Iain H McKillop; Mark W Russo; Herbert L Bonkovsky; Laura W Schrum
Journal:  Hepatology       Date:  2012-06-18       Impact factor: 17.425

6.  miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice.

Authors:  Zhipeng Meng; Xianghui Fu; Xiaosong Chen; Samuel Zeng; Yan Tian; Richard Jove; Rongzhen Xu; Wendong Huang
Journal:  Hepatology       Date:  2010-10-26       Impact factor: 17.425

7.  Gα12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells.

Authors:  Kyu Min Kim; Chang Yeob Han; Ji Young Kim; Sam Seok Cho; Yun Seok Kim; Ja Hyun Koo; Jung Min Lee; Sung Chul Lim; Keon Wook Kang; Jae-Sung Kim; Se Jin Hwang; Sung Hwan Ki; Sang Geon Kim
Journal:  J Hepatol       Date:  2018-01-02       Impact factor: 25.083

Review 8.  microRNAs: fad or future of liver disease.

Authors:  Ashley M Lakner; Herbert L Bonkovsky; Laura W Schrum
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 9.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

Review 10.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.